- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0045069

Ncyte Pharma Private Limited
About Ncyte Pharma Private Limited
Data last updated:
Ncyte Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 26 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC128505. Its GSTIN is 36AAGCN2970B1ZN (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Radhika Noone and Noone Sreenivasa Rao.
Its last annual general meeting (AGM) was held on 28 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sy No 9/1/G H No 11 – 11 – 443/56 5th Floor Surya Towers Road No 7 Telephone Colony, Hyderabad, Telangana, India – 500035.
As per the financials filed for FY 2024, the company reported a revenue of ₹60.9 Lakh, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹78,297 (net margin 1.3%) and EBITDA of ₹78,981 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years.
Ncyte Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0045069).
Company details
Recognitions & Rankings of Ncyte Pharma
Contact details
Ncyte Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressSy No 9/1/G H No 11 – 11 – 443/56 5th Floor Surya Towers Road No 7 Telephone Colony, Hyderabad, Telangana, India – 500035
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ncyte Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ncyte Pharma Private Limited, buy the company report.
Financials of Ncyte Pharma Private Limited
FY 2025 filings availableNcyte Pharma Private Limited reported revenue of ₹60.9 Lakh (up 44% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 65% over three years, including 44% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78,981 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹78,297 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ncyte Pharma Private Limited, buy the company report.
Board of directors of Ncyte Pharma Private Limited
Ncyte Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Radhika Noone | Director | 26 Nov 2018 | 7 Years 11 Months | Current |
| Noone Sreenivasa Rao | Director | 26 Nov 2018 | 7 Years 11 Months | Current |
Peer comparison
Ncyte Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Musskito Febstyle (India) Private Limited | ₹60.92 Lakh (FY 2025) | -1.0% | Kanpur, Uttar Pradesh, India | |||
| P.C. Coomar & Sons Hard Ware Pvt Ltd | ₹60.91 Lakh (FY 2025) | 10.0% | Kolkata, West Bengal, India | |||
| Ashirvad Sales Private Limited | ₹60.9 Lakh (FY 2025) | 464.0% | Varanasi, Uttar Pradesh, India | |||
| Sinnar Gases Private Limited | ₹60.9 Lakh (FY 2025) | 9.0% | Nashik, Maharashtra, India | |||
| Chirantan Properties Pvt Ltd | ₹60.9 Lakh (FY 2024) | 7.0% | Kolkata, West Bengal, India | |||
| Ncyte Pharma Private Limitedthis company | ₹60.9 Lakh (FY 2024) | ₹78,297 | 1.3% | 44.0% | Hyderabad, Telangana, India | |
| Baglamukhi Agencies Limited | ₹60.89 Lakh (FY 2018) | 556.0% | Howrah, West Bengal, India | |||
| Marediya Electrotech Private Limited | ₹60.89 Lakh (FY 2024) | 37.0% | Palanpur, Gujarat, India | |||
| Ashok Steels Limited | ₹60.89 Lakh (FY 2025) | 47.0% | Hazaribagh, Jharkhand, India | |||
| Jashsinh Overseas Private Limited | ₹60.88 Lakh (FY 2025) | 39.0% | Ahmedabad, Gujarat, India | |||
| Layronix Life Sciences Private Limited | ₹60.86 Lakh (FY 2024) | 125.0% | New Delhi, Delhi, India |
To see the full peer comparison of Ncyte Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ncyte Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ncyte Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ncyte Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCN2970B1ZN | Telangana | Active | 10 Jan 2019 |
To see the full GST registrations and return filing status of Ncyte Pharma Private Limited, buy the company report.
Recent activity
Ncyte Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Noone Sreenivasa Rao was appointed as Director on 26 Nov 2018.
Frequently asked questions
Ncyte Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in other services, within the business services industry. It was incorporated on 26 November 2018 (8+ years old) and is registered under CIN U74999TG2018PTC128505.
Ncyte Pharma has 2 current directors:
- Radhika Noone - Director
- Noone Sreenivasa Rao - Director
The latest financial statements of Ncyte Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 November 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Ncyte Pharma is 36AAGCN2970B1ZN, registered in Telangana.
The CIN (Corporate Identification Number) of Ncyte Pharma is U74999TG2018PTC128505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ncyte Pharma was incorporated on 26 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ncyte Pharma by revenue are Musskito Febstyle (India) Private Limited, P.C. Coomar & Sons Hard Ware Pvt Ltd, Ashirvad Sales Private Limited, Sinnar Gases Private Limited, Chirantan Properties Pvt Ltd and 5 more, all in the same principal business activity (wholesale trading).
Noone Sreenivasa Rao was appointed as Director on 26 Nov 2018. Radhika Noone was appointed as Director on 26 Nov 2018.
Yes, Ncyte Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0045069).
The registered office of Ncyte Pharma is at Sy No 91G H No 11 – 11 – 44356 5th Floor Surya Towers Road No 7 Telephone Colony, Hyderabad, Telangana, India – 500035.
Ncyte Pharma operates in the business services industry, in the other services segment.

